Здоровье
Подозреваемая подделка Ozempic привела к госпитализации нескольких человек в Австрии
Several people were hospitalised in Austria after consuming suspected counterfeit versions of the diabetes drug Ozempic, the country’s health safety agency said. The patients suffered
Nestle начинает работу над «продуктами-компаньонами» для лекарств для похудения
Nestle on Thursday said it has started work on products that will “complement” weight-loss drugs such as Novo Nordisk’s revolutionary Wegovy, hoping to capitalise on
Европейский регулятор предупреждает ЕС и Великобританию о поддельных ручках Ozempic
The European medicines regulator on Wednesday warned of pre-filled pens falsely labelled as Novo Nordisk’s popular diabetes drug Ozempic at wholesalers in the European Union
Pfizer установит цену на лечение COVID-19 препаратом Паксловид на уровне $1390 за курс
Pfizer on Wednesday said it would set the U.S. price for its COVID-19 antiviral drug Paxlovid at nearly $1400 for a five-day course when the
Hyloris Pharma получила одобрение FDA США на свое лекарство от боли
US health regulators have approved Hyloris Pharmaceuticals’ drug for post-operative pain, the Belgian company said on Wednesday, adding that it expects to launch the non-opioid
Регулятор ЕС поддерживает использование препарата Merck для лечения вирусных инфекций
Merck & Co said the European Union’s medicines regulator has recommended a registration authorisation for the company’s Prevymis drug to treat a type of infection
Препарат Кейтруда компании Merck получил одобрение FDA на расширение его применения при раке легких
The US Food and Drug Administration has approved the expanded use of Merck & Co’s blockbuster immunotherapy Keytruda in early-stage patients with non-small cell lung
Омерос останавливает разработку терапии заболеваний почек после провала исследования
Omeros Corp. said Monday it will stop developing an experimental therapy to treat a certain type of kidney disease after a late-stage study failed and
Италия будет взимать с иностранцев 2000 евро в год за медицинское обслуживание
Foreigners living in Italy will be able to use the national health service after paying an annual fee of 2,000 euros ($2,109), the government said
Labcorp запускает трехэтапный анализ крови на болезнь Альцгеймера
Labcorp has begun selling U.S. doctors the first test for three blood biomarkers they say can detect signs of Alzheimer’s disease, speeding diagnosis of the